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Role of the mitral valve in snbaortic abstraction. Because 
the left ventricle, in contrast to the right, has no separate inflow 
and outflow tract, it has to be converted from an inflow 
chamber in diastole to an outflow chamber in systole (1). This 
conversion is achieved by the anterior mitral leaflet switching 
like a relay from the septum toward the posterior wall, where 
it is tethered in systole by the papillary muscles. These muscles 
arise posteriorly and restrain the coapted leaflets below the 
outflow stream, which can proceed unimpeded; any disruption 
of this tethering mechanism, therefore, has the potential to 
allow the leaflets to move anteriorly and obstruct outfiow. Such 
changes are well recognized to occur in hypertrophic cardio- 
myopathy, in which anterior displacement of the papillary 
muscles and mitral leaflet elongation diminish the effective 
tethering of the leaflets posteriorly and provide sufficient 
leaflet mobility to allow systolic anterior motion (SAM) of the 
leaflets, obstructing the outflow tract (2-11). Obstructive hy- 
pertrophic cardiomyopathy is therefore as much a disease of 
the mitral valve as it is of the myocardium. As a consequence, 
particularly in patients regarded as suboptimal candidates for 
septal myectomy, attempts have been directed to aboliih 
outflow tract obstruction and mitral regurgitation by mitral 
valve surgery, the most definitive approach being excision of 
the native valve and replacement h, a prosthesis (12). To avoid 
the limitations of prostheses, mitrai valve plication has recently 
been introduced by McIntosh et al. (13) as an adjunctive 
procedure for patients judged at operation to be at increased 
risk for suboptimal hemodynamic results from septal myec- 
tomy alone. The decision to reduce anterior leaflet width by 
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plication is guided by intraoperative and preoperative echocar- 
diography and direct observations of an enlarged and elon- 
gated anterior mitral leaflet persisting to prolapse into the 
outflow tract with septal contact despite apparently adequate 
muscular resection. This approach has yielded excellent hemo- 
dynamic and symptomatic results comparable to those of 
myectomy alone in patients without substantially enlarged 
mitral leaflets (13). 
Anterior mitral leaflet extension. Whereas mitral valve 
plication reduces anterior leaflet size and thus follows the logic 
of pathoanatomic and echocardiographic studies of the mech- 
anism of SAM, Kotllard et al. (14) in this issue of the Journal 
propose the exact opposite- horizontal anterior mitral leaflet 
extension-and with apparently no less impressive results. In a 
series of eight patients in whom the surgeon considered 
myectomy alone unlikely to yield optimal results, a 
glutaraldehyde-preserved autologous pericardial patch was 
inserted into the anterior Icaflet, in a modification of a 
technique initially developed by Carpentier to treat mitral 
regurgitation in rheumatic valvular disease and bacterial en- 
docarditis with perforation (15). 
Why does it work? As suggested by the authors, the patch 
extends across the bending point of the buckling anterior 
leaflet and may stiffen it, preventing SAM. If this is the 
principal mechanism, simply sewing a pericardial patch onto 
the central portion of the leaflet would be expected to do the 
job without changing leaflet dimension. The basis for another 
explanation is the obseriation that SAM is typically greatest at 
the leaflet center (2,3,5,7), consistent with increased slack of 
the related chordae (e.g., created by inward or central displace- 
ment of the papillary muscle tips. as Seen in hypertrophic 
obstructive cardiomyopathy). The authors therefore propose 
that inserting the central patch may displace the chordae 
inserting into the central leaflet laterally, thus stretching them 
and increasing leaflet tethering. Further, taking the anterior 
leaflet margins, which have been incised along a straight tine, 
and deforming them to follow the longer elliptical outline of 
the patch should make the leaflet slightly shorter because 
leaflet area and mass remain the same; this change would 
therefore reduce the slack needed to produce SAM. 
An alternative hypothesis would be the additive beneficial 
impact of increased leaflet area once the streamlines of flow 
have been normalized by septal myectomy. In the presence of 
a hypertrophied basal anterior septum bulging intb the cavity, 
blood flow cannot take the dirm route from the apex to the 
out&w tract, but must circumvent the septum (Fig. 1). The 
streamlines of flow are therefore curved and may hit the 
anterior leaflet on its posterior surface, pushing it toward the 
septum. Once normalization (straightening) of the intraven- 
tricular streamlines has been achieved by subvalvular myec- 
tomy, flow is directed onto the anterior surface of the mitral 
leaflets, as in normal hearts; in this case, increasing leaflet area 
by horizontal ,extension (which probably does not increase 
leatlet slack) will be benelicial in preventing SAM and mitral 
regurgitation because the anterior leaflet is then pressed 
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Figam 1. Top, In addition to the force generated by the papillary 
muscles (directed apically and posteriorly, as shown by the arrows 
below the mitral valve), the flow that is directed onto the anterior 
surface of the mitral leaflet contributes to keeping the mitral valve 
posteriorly with a force that equals left ventricular pressure times the 
area of the leaflet exposed to that pressure. Bottom, Because of a 
hypertrophied basal anterior septum bulging into the cavity, blood flow 
cannot take the direct path from the apex to outflow tract, but 
necessarily must circumvent the septum. The streamlines of flow are 
therefore curved and may hit the anterior leaflet on its posterior 
surface, dragging it toward the septum; leaflet mobility to follow the 
forces of the flow field is facilitated by abnormal mobility of the mitral 
valve due to leaflet elongation and anterior displacement of the 
papillary muscles. AML = anterior mitral leaflet; Ao = aorta: LA = 
left atrium; LV = left ventricle; HOCM = obstructive hypertrophic 
cardiomyopathy; IVS = interventricular septum; PML = posterior 
mitral leatlet; PO = posterior wall of the left ventricle. 
posteriorly by a force that is proportional to the leaflet area 
exposed to flow. In fact, a flow stream directly impacting on the 
anterior surface of a tethered mitral leaflet in vitro actually 
maintains its posterior position and effectively opposes the lift 
or Venturi force created by a higher velocity outflow stream 
not impacting on the leaflet surface (16). The practical impli- 
cation of this mechanism is that horizontal leaflet extension 
would be helpful after septal myectomy (in a synergistic 
manner) but would not necessarily reduce SAM without it, 
whereas mitral leaflet plication has the potential to reduce or 
even abolish SAM independently; leaflet stiffening caused by 
the patch, of course, would reduce SAM independent of 
myectomy as well. 
Another observation of mechanistic interest is that mitral 
regurgitation, which was more severe before operation in the 
group undergoing leaflet extension, was abolished more effec- 
tively by providing greater leaflet area; this is consistent with 
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previous observations, both in vitro and in patients, that 
increased leaflet contact area reduces mitral regurgitation for 
a given degree of SAM (11.17,18). 
Does it work? ‘Proving the value of an additional mitral 
valve intervention ‘after myectomy wculd require either dem- 
onstrating more effective results with than without mitral valve 
surgery (either in the same patients or in matched groups, not 
chosen in the present study) or demonstrating good hemody- 
namic results with additional mitral valve surgery in patients 
known to do poorly with myectomy alone, as the authors set 
out to do. It is not clear, however, that such proof is available 
on the basis of the selection process in this study, which related 
to the impression regarding expected hemodynamic outcome. 
Obviously, the severity of mitral regurgitation favored mitral 
valve extension. Other conditions generally favoring mitral 
valve surgery, such as limited septal hypertrophy, although 
mentioned in the methods and discussion sections, did not 
appear to play an actual role: There was no difference in the 
range of septal thickness in the group with and without 
additional mitral leaflet extension (20 to 35 mm vs. 20 to 
33 mm). Moreover, in the group undergoing additional mitral 
leaflet extension, myectomy was significantly more effective in 
reducing septal thickness (19 t4mmvs.22?4mm,p<0.05, 
Table 2 [14]). In view of the limited number of patients, as the 
authors note, it cannot be excluded that at least some of the 
beneficial effect attributed to the additional mitral leaflet 
extension was actually caused by a more effective myectomy in 
the leaflet extension group. No information is provided as to 
whether there was a difference in mean mitral leaflet area 
between the two groups, although it is mentioned that all 
patients in both groups had clearly enlarged leaflets, and 
whether differences in leaflet length and area could potentially 
be valuable for selecting the appropriate procedure. Finally, it 
is not clear why postoperative functional class was better in the 
leaflet extension group despite a comparable hemodynamic 
result. The differences in functional class cannot all be related 
to decreased residual mitral regurgitation (Table 1 [14]). It is 
even conceivable that the effect of medication (such as antiar- 
rhyth&c agents or a combination of beta-adrenergic blocking 
agents and calcium antagonists, which has been shown to 
increase pulmonary artery pressure significantly without any 
beneficial effect compared with each drug alone [19]) may have 
contributed to the decreased functional capacity of the patients 
undergoing myt ctomy alone, who were taking more medica- 
tions postoperatively (Table 2 (141). A placebo effect in 
patients who know they have undergone an “improved” pro- 
cedure also cannot be excluded without objective exercise 
testing, which can safely be performed in these patients 
(20,21), particularly after relief of outflow tract obstruction. 
Is it necessary? Subvalvular myectomy has been shown to 
be an effective treatment for symptomatic patients with ob- 
structive hypertrophic cardiomyopathy refractory to medical 
treatment that can be performed with low mortality and 
morbidity in experienced hands, yielding excellent symptom- 
atic and hemodynamic long-term results, with an experience of 
>25 years (22-26). A subset of patients, however, may be 
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difficult to manage without additional mitral valve surgery, 
even in experienced hands (13,14), and could therefore benefit 
from mitral leaflet plication or extension. Definite proof of the 
superiority of combined myectomy and mitral valve repair 
would require a staged approach, with assessment of hemody- 
namic variables by intraoperative echocardiography after my- 
ectomy alone (off bypass) and then after the additional mitral 
valve repair. (Such multiple bypass times are routinely used in 
some centers [27] for optimizing myectomy by intrroprative 
echocardiography and thus do not involve the ethicai problems 
posed by a randomized study in this context.) Quantification of 
mitral leaflet geometry by intraoperative echocardiography 
could potentially help us to develop clearly defined indications 
for mitral valve repair as well as guide the procedure. Never- 
theless, the study by Kofflard et al. (14) is consistent with 
growing evidence that structural abnormalities of the mitral 
apparatus can play a primary role in causing SAM and dynamic 
subaortic obstruction (2-11,28,29). In hypertrophic cardiomy- 
opathy, SAM can be viewed as the result of an abnormal mitral 
valve apparatus exposed to an abnormal flow field; kafiet 
extension after myectomy addresses both of these factors. 
Systolic anterior motion after mitral valve repair for myxoma- 
tous prolapse can also be related to slack leaflet portions 
interposed into the outilow stream because the posterior 
leaflet is elongated and shifts the coaptation point anteriorly 
(30-33). These observations are consistent with lessons 
learned from experimental and computational models studying 
the interaction of the mitral valve and outflow stream (5 
7,16,34-38). This increased understanding has direct practical 
implications for surgical management, and it is our expectation 
that detailed cardiac ultrasound imaging of the underlying 
anatomy (39) will allow new techniques to be applied most 
effectively to the individual patient to provide the most normal 
function and the greatest benefit. 
We thank Karen Rqynolds, MPH. for expert assistance 
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